Toronto, Ontario--(Newsfile Corp. - February 16, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that Dr. Robin Black has been added to the Company's board of directors. In addition, the Company would like to provide an update on its audit of its financial statements for the year ended December 31, 2023.

Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce the appointment of Mr. Robert Caines as Chief Financial Officer ("CFO") of the Company.

Toronto, Ontario--(Newsfile Corp. - December 14, 2023) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms to its customers and stakeholders that following a recent cyber attack the Company has successfully restored its systems and resumed full-scale operations stronger than ever.

VANCOUVER, BC, Oct. 5, 2023 /CNW/ - Trading resumes in:

Toronto, Ontario--(Newsfile Corp. - October 3, 2023) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to provide an update respecting the reinstatement to trading of its common shares on the TSX Venture Exchange (the "Exchange") under the trading symbol "EKG". The Exchange has confirmed that trading of the Company's shares will be reinstated on or about Friday, October 6, 2023.

Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces a cyber security incident on the Company's servers.

Toronto, Ontario--(Newsfile Corp. - May 10, 2023) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that on May 8, 2023 the TSX Venture Exchange suspended trading in the Company's securities as a result of a Cease Trade Order (the "CTO") issued by the Ontario Securities Commission. The CTO was issued due to the Corporation missing the deadline to file its annual financial statements for the financial year ended December 31, 2022 (the "Financial Statements") and its management's discussion and analysis relating to the Financial Statements (collectively, the "Required Filings") before the prescribed deadline of May 1, 2023 (see the Company's press release dated May 1, 2023 for further details).

VANCOUVER, BC, May 8, 2023 /CNW/ - The following issues have been halted by IIROC:

Toronto, Ontario--(Newsfile Corp. - May 1, 2023) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced today that it will not file its annual financial statements for the financial year ended December 31, 2022 (the "Financial Statements") and its management's discussion and analysis relating to the Financial Statements (collectively, the "Required Filings") before the prescribed deadline of May 1, 2023 (the "Filing Deadline").

Toronto, Ontario--(Newsfile Corp. - January 30, 2023) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has completed an issuance of shares for debt (see the Company's press release dated December 23, 2022 for the Company's initial announcement respecting the proposed shares for debt issuance) and confirms completing changes to its Board of Directors.

Toronto, Ontario--(Newsfile Corp. - December 23, 2022) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it has secured a two year term renewal on $130,000 in loans which had a maturity date of December 31, 2022.

Collaboration to Add Comprehensive Arrhythmia Monitoring Services Under CareXM's TouchPointCare Telemedicine Platform

Toronto, Ontario--(Newsfile Corp. - July 28, 2022) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has issued 125,000 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately. The grant is subject to the provisions of the Company's Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.

Toronto, Ontario--(Newsfile Corp. - February 3, 2022) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it has completed an issuance of shares for debt (see the Company's press release dated December 31, 2021 for the Company's initial announcement respecting the proposed shares for debt issuance).

Toronto, Ontario--(Newsfile Corp. - December 31, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it has entered into a revolving line-of-credit loan agreement dated as of December 18, 2021, representing additional available funding as needed of up to $230,000. The terms of the loan require that any borrowed amounts be repaid by the Company, along with interest at 8% per year, by no later than December 18, 2023. The loan is secured against the assets of the Company.

New health monitoring device integrations, including wearables, and new software releases will support medical and consumer wearable market demand for credible patient monitoring solutions

Toronto, Ontario--(Newsfile Corp. - November 3, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has issued 125,000 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately. The grant is subject to the provisions of the Company's Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.

Toronto, Ontario--(Newsfile Corp. - May 12, 2021) -  CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it has completed its previously announced issuance of shares for debt (see the Company's press releases dated April 27, 2021 and April 8, 2021 for further details).

Toronto, Ontario--(Newsfile Corp. - April 27, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced the proposed issuance of shares for debt and the issuance of stock options.

Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced the proposed issuance of shares and the issuance of stock options.

New ISO 13485:2016 MDSAP scope paves the way to integration of novel and multiple bio sign monitoring devices for broader patient monitoring solution sales to the consumer and Rx markets globally

Toronto, Ontario--(Newsfile Corp. - January 10, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is confirming the appointment of a new Chief Financial Officer and completion of a debt to equity settlement.

Debt to equity conversion follows new releases

Patient Self-Monitoring with ECG Triaging Services will Support Remote Monitoring Needs

TORONTO, ON / ACCESSWIRE / December 22, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms that it has secured renewals on $500,000 in loans which had a maturity date of December 31, 2020.

Patient Self-Monitoring Extends Physicians' Reach for Monitoring During COVID-19

HeartCheck™ CardiBeat and SMART Monitoring ECG Triaging to be used in Screening Services for detection of QT Prolongation in Community Pharmacies

GEMS™ Mobile and the HeartCheck™ CardiBeat Integrated with the LiveCare Link+ Platform

TORONTO, ON / ACCESSWIRE / November 30, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has issued 62,500 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately. The grant is subject to the provisions of the Company's Stock Op

TORONTO, ONTARIO / ACCESSWIRE / July 17, 2020 / CardioComm Solutions, Inc. (TSXV:EKG)(OTC PINK:EKGGF) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has issued 62,500 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately. The grant is subject to the provisions of the Compa

TORONTO, ONTARIO / ACCESSWIRE / May 31, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, provides an update respecting its reliance on the coordinated relief provided by securities regulators, which consists of a 45-day extension for certain periodic filings required on or before June 1, 2020, pursuant to Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements

TORONTO, ONTARIO / ACCESSWIRE / April 30, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it is relying on the coordinated relief provided by securities regulators, which consists of a 45-day extension for certain periodic filings required on or before June 1, 2020, pursuant to Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements and simi

TORONTO, ON / ACCESSWIRE / April 22, 2020 / CardioComm Solutions, Inc. (TSX.V:EKG)(OTCPINK:EKGGF) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has issued 62,500 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately. The grant is subject to the provisions of the Company&#

TORONTO, ON / ACCESSWIRE / February 12, 2020 / CardioComm Solutions, Inc. (TSX-V:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has completed its previously announced issuances of shares for services and debt.

TORONTO, ONTARIO / ACCESSWIRE / January 22, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced the proposed issuance of shares and the issuance of stock options.

GEMS™ Mobile and the HeartCheck™ CardiBeat to be integrated with the CareOS smart mirror

Patient Self-Monitoring Extends Physicians' Reach for Proactive Monitoring of Atrial Fibrillation Recurrence and any Arrhythmia.

ECG technologies to be tested within ZANA's remote patient monitoring platform in 2020

Device certification to meet underserviced Canadian market needs for long-term, remote ECG recording and ECG management software solutions.

MDSAP Certification to Expand Market Access for CardioComm's Medical Devices and Software

Toronto, Ontario--(Newsfile Corp. - October 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces shares and options.

Toronto, Ontario--(Newsfile Corp. - September 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will make its fourth issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company previously announced the online marketing and awareness program in press releases dated November 8, 2018 and December 13, 2018.

Toronto, Ontario--(Newsfile Corp. - July 2, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces shares and options.

Toronto, Ontario--(Newsfile Corp. - June 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) (OTC PINK: EKGGF) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will make its third issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company previously announced the online marketing and awareness program in press releases dated November 8, 2018 and December 13, 2018. Under this third share issuance to AGORACOM, the Company will issue 188,333 common shares of the Company ("Shares"), representing a price of $0.06 per Share, for services valued at $10,000 plus 13% HST that were provided by AGORACOM during the third share issuance period.

Integration of GEMS(TM) Universal ECG App with BodiMetrics hardware platform expands ECG Device Manufacturer's Offerings to now Include Credible ECG Reporting Services

Health Canada and FDA Approved GEMS Mobile ECG App Expands Credible ECG Reporting Services Across Global Markets

The Bluetooth HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Smartphone App will Target Home, Outpatient, Telemedicine and Cardiac Arrhythmia Monitoring Markets

Toronto, Ontario--(Newsfile Corp. - April 12, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms that it has repaid $100,000 in outstanding loans and that the remaining $500,000 in loans, which would have otherwise matured on March 31, 2019, have been extended by the lenders.

Bluetooth Connected HeartCheck CardiBeat and GEMS Mobile Smartphone App to Target Underserviced Canadian Home and Telemedicine Arrhythmia Monitoring Markets

Awareness program to expand distribution of Company's updates to retail and institutional investors

Awareness program to expand distribution of Company's updates to retail and institutional investors

Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, issued 125,000 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per share for five years from the date of grant and vest immediately. The grants are subject to the provisions of the Company's Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.

FDA Approval of New Version of GEMS Mobile ECG App Will Result in Growing Number of Partnerships with ECG Device Manufacturers

ECG Device Manufacturer Partnerships Grow as FDA Cleared GEMS(TM) Mobile Smartphone ECG App Expands Device Access to Consumer and Telemedicine Cardiac Monitoring Solutions

GlobalCardio 12 FLEX Supports Traditional 12-Lead ECG Devices and New Wearable Options for In-Clinic and In-Home Use

Apps for Automated Atrial Fibrillation and Prolonged QT Interval Detection will be Included in the Scope of Detection Options

The HeartCheck(TM) CardiBeat and GEMS(TM) Mobile App Supports Both iOS and Android Smartphones for use in Consumer, Clinical Research and Telemedicine Cardiac Monitoring Solutions

VANCOUVER, Feb. 25, 2019 /CNW/ - Trading resumes in:

VANCOUVER, Feb. 22, 2019 /CNW/ - The following issues have been halted by IIROC:

Move is Part of Growing Sales, Marketing and Strategic Partnership Activities in the United States

The Novel 12 Lead ECG Belt will be Marketed into the US Hospital and Telemed Markets

HeartCheck(TM) CardiBeat and GEMS(TM) Mobile review results expected in late February

Collaboration with the University of Victoria opens the pathway to three FDA applications

FDA Removes Additional Clinical Testing Requirements for the HeartCheck CardiBeat

Toronto, Ontario--(Newsfile Corp. - December 27, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms the renewal of $600,000 in loans that would have matured December 31, 2018.

ECG technology integration across CREO's platform to be launched in 2019

Awareness program to expand distribution of Company's updates to retail and institutional investors

MDSAP Certification Completion Will Expand Market Access to CardioComm's Medical Devices and Software

New CFO will provide additional bench strength to management team heading into 2019

Market Release of HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Application Set For Early 2019

Toronto, Ontario--(Newsfile Corp. - November 8, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it is implementing an online marketing and awareness program through AGORA Internet Relations Corp. ("AGORACOM").

Toronto, Ontario--(Newsfile Corp. - October 30, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced its joint partnership sales plans for the commercial launch of its newest software release designed to support an innovative and easy to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia monitoring wearable smart garment manufactured by Israel-based HealthWatch Technologies Ltd. ("HealthWatch").

Toronto, Ontario--(Newsfile Corp. - October 22, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions confirmed today progress on a royalty licencing agreement with Redwood City, California-based Biotricty Inc. ("Biotricity"). The royalty payment phase became active following confirmation that all necessary clearance and software development pre-conditions have been achieved.

Toronto, Ontario--(Newsfile Corp. - September 27, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, firmly responds to recent technology companies' announcements that it was the first company to be approved to sell an ECG product directly to consumers over the counter ("OTC") in North America. 

Toronto, Ontario--(Newsfile Corp. - September 8, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced that it is seeking approval from the TSX Venture Exchange to extend the expiry dates of outstanding warrants exercisable to purchase an aggregate of 8,346,000 common shares of the Company at $0.075 per share. 7,300,000 of the warrants were issued by the Company on December 23, 2016 by way of a private placement and currently have an expiry date of December 23, 2018. The Company is seeking to extend the expiry date of these warrants until December 23, 2020. 1,046,000 of the warrants were issued by the Company on February 3, 2017 by way of a private placement and have an an expiry date of February 3, 2019. The Company is seeking to extend the expiry date of these warrants until February 3, 2021. All other terms and conditions of the warrants remain unchanged.

Toronto, Ontario--(Newsfile Corp. - August 13, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms its HeartCheck™ device and GEMS™ software technologies have moved into routine clinical use following completion of a long-term, remote arrhythmia monitoring pilot in high risk patients.

Toronto, Ontario--(Newsfile Corp. - August 13, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms its HeartCheck™ device and GEMS™ software technologies have moved into routine clinical use following completion of a long-term, remote arrhythmia monitoring pilot in high risk patients.

Toronto, Ontario--(Newsfile Corp. - August 2, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received a request for additional information from the USA Food and Drug Administration ("FDA") following the Company's filing of its premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile application.

Toronto, Ontario--(Newsfile Corp. - May 29, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, issued 62,500 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per share for five years from the date of grant and vest immediately. The grants are subject to the provisions of the Company's Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.

Toronto, Ontario--(Newsfile Corp. - May 22, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms it has filed an application with the USA Food and Drug Administration ("FDA") for premarket notification 510(k), Class II medical device clearance of the Company's newest HeartCheck™ branded, handheld heart rhythm monitor.

Toronto, Ontario--(Newsfile Corp. - May 8, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has initiated the application process to the USA Food and Drug Administration ("FDA") for premarket notification 510(K), Class II medical device clearance of the Company's newest consumer-based and HeartCheck™ branded, hand-held heart rhythm monitor.

Toronto, Ontario--(Newsfile Corp. - April 30, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") software solutions, released its 2017 year-end financials, demonstrating continued sales growth, a profitable 2017 and increased confidence from the Company's auditor.

Toronto, Ontario--(Newsfile Corp. - April 30, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company") today announced that its board of directors has adopted an advance notice policy (the "Advance Notice Policy").

Toronto, Ontario--(Newsfile Corp. - March 5, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company") is pleased to announce that it held business meetings with 25 technology companies during an Ontario Trade Delegation visit to Japan and Korea from February 20 to 27. The meetings were arranged through the assistance of the Ontario Ministry of International Trade with Global Affairs Canada representatives in Japan and Korea, the Osaka Prefecture Government, Economic Affairs Government of Ontario at the Embassy of Canada to Korea, Intralink Limited and direct marketing efforts by CardioComm. The Company confirmed the likelihood of letters of intent and cooperation agreements to result over the next few months.

Toronto, Ontario--(Newsfile Corp. - February 22, 2018) - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSXV: EKG) is participating in a series of meetings organized by the Ontario Trade Commission in partnership with Global Affairs Canada which has led to a delegation visit to Japan and Korea from February 20th to 27th.

Toronto, Ontario--(Newsfile Corp. - December 18, 2017) - Global medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm Solutions" or the "Company"), today confirmed that it has officially released GEMS™ Home Flex for HeartCheck™ ECG devices that work on either a Mac or Windows operating system.

Toronto, Ontario--(Newsfile Corp. - November 23, 2017) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced the appointment of Bank of Montreal veteran Mr. Steven Benyo, CPA, CA as the newest member of the Company's Board of Directors ("BOD") and as a member of the Company's Audit and Finance Committee.

VANCOUVER, Nov. 20, 2017 /CNW/ - Trading resumes in:

Vancouver, British Columbia--(Newsfile Corp. - November 20, 2017) - Trading resumes in:

Toronto, Ontario--(Newsfile Corp. - November 20, 2017) - Established medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company") today confirmed it has entered into a supply and service agreement with Quebec-based Servier Canada Inc. ("Servier") for the coordination of a new handheld ECG monitor loan program.

VANCOUVER, Nov. 20, 2017 /CNW/ - The following issues have been halted by IIROC:

Vancouver, British Columbia--(Newsfile Corp. - November 20, 2017) - The following issues have been halted by IIROC:

Toronto, Ontario--(Newsfile Corp. - November 7, 2017) - Established medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company") today confirmed it has been recognized as one of the 10 Most Promising Patient Monitoring Solution Providers for 2017 by California-based technology magazine CIOReview.

Toronto, Ontario--(Newsfile Corp. - October 25, 2017) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced the appointment of Dr. John Foote, MD, CCFP(EM) from Mount Sinai Hospital, Toronto, Ontario, as the newest member of the Company's Board of Directors ("BOD") and the resignation of BOD member Mr. William Smith.

Palm Desert, CA, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytta Corp. (OTCPINK:CYCA), a leading provider of mobile smartphone and web based healthcare technology solutions, and CardioComm Solutions, Inc. (“CardioComm”) (TSX VENTURE:EKG), a Canada based global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software and hardware solutions, today announced completion of a Joint Venture Agreement (“Agreement”)....

Toronto, Ontario--(Newsfile Corp. - October 2, 2017) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") management software solutions, today announced that it has completed a custom software engineering contract with UK based Remote Diagnostic Technologies Limited ("RDT") for development and licensing of a remote, cloud-based, 12 lead ECG management and ECG reading solution. RDT specializes in the design of highly integrated mobile, vital signs, tele-monitoring solutions used globally.

VANCOUVER, April 24, 2017 /CNW/ - Trading resumes in:

VANCOUVER, April 24, 2017 /CNW/ - The following issues have been halted by IIROC:

VANCOUVER, Dec. 29, 2016 /CNW/ - Trading resumes in:

VANCOUVER, Dec. 29, 2016 /CNW/ - The following issues have been halted by IIROC:

VANCOUVER, May 31, 2016 /CNW/ - Trading resumes in:

VANCOUVER, May 31, 2016 /CNW/ - The following issues have been halted by IIROC:

VANCOUVER, April 18, 2016 /CNW/ - Trading resumes in:

VANCOUVER, April 18, 2016 /CNW/ - The following issues have been halted by IIROC:

VANCOUVER, March 17, 2016 /CNW/ - Trading resumes in:

VANCOUVER, March 17, 2016 /CNW/ - The following issues have been halted by IIROC: